SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Business
Genentech, Inc. Signs 121,000SF Bay Area Biotech Lease
June 9, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Encysive Pharmaceuticals Re-Submits Thelin
May 25, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Gets OK To Restart Avastin Trial
May 23, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Merck & Co., Inc. Gobbles Up Two Biotechs
May 9, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Northstar Neuroscience, Inc. IPO Very Successful
May 5, 2006
 · 
1 min read
Job Trends
SF Bay Area Jobs; Genentech, Inc. Increased Workforce 24%
May 5, 2006
 · 
1 min read
Biotech Bay
Ready For A Rally
May 2, 2006
 · 
7 min read
Biotech Bay
Genentech, Inc. Is Weird
April 13, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Biotech IPOs Get Chilly Reception
April 12, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Deals
Genentech Scoops Up Tumor-Starving Drug Program From FORMA Therapeutics In Rare Deal
June 27, 2011
 · 
1 min read
Drug Development
Roche’s Genentech’s Drug Positive in Mid-Stage Skin Cancer Trial
June 20, 2011
 · 
1 min read
Business
Marshall Edwards, Inc. Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer
June 2, 2011
 · 
5 min read
Drug Development
Genentech Release: MetMAb in Combination with Tarceva Doubled the Time People with Lung Cancer Lived without Their Disease Getting Worse
May 19, 2011
 · 
1 min read
Drug Development
Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at American Society of Clinical Oncology
May 18, 2011
 · 
1 min read
FDA
FDA Approves Genentech’s Actemra to Treat Rare Form of Juvenile Arthritis
April 15, 2011
 · 
3 min read
Drug Development
Early-Stage Genentech Cancer Drug Combo Shows Promise
April 5, 2011
 · 
1 min read
Drug Development
Genentech Release: Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME)
March 25, 2011
 · 
8 min read
Drug Development
Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma
March 21, 2011
 · 
1 min read
Drug Development
Curis, Inc. Announces Positive Results in Genentech Pivotal Phase II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma
March 21, 2011
 · 
7 min read
Load More